Defunct Company
Total Trials
9
As Lead Sponsor
0
As Collaborator
Total Enrollment
53,375
NCT03151070
Scaling Up an Integrated Approach to Improve Delivery Care in North Guatemala With Stepped Wedge Design
Phase: N/A
Role: Collaborator
Start: Dec 15, 2013
Completion: Mar 15, 2017
NCT03422575
Bioequivalence Study of 120 mg Etoricoxib Film-coated Tablets
Start: Dec 31, 2015
Completion: Mar 31, 2016
NCT04517760
Evaluating an HIV Risk Screening Tool for Orphans and Vulnerable Children in Tanzania
Start: Feb 22, 2018
Completion: Sep 30, 2019
NCT06817811
Bioequivalence Study of Apixaban 5 mg Film-Coated Tablet
Phase: Phase 1
Start: Apr 15, 2021
Completion: Jun 3, 2021
NCT05025722
Pseudoxanthoma Elasticum (PXE) Natural History Biomarkers in PXE Individuals and Their Biological Non-PXE Siblings
Start: Aug 30, 2021
Completion: Aug 11, 2022
NCT05569252
A Study of DS-1211b in Individuals With PseudoXanthoma Elasticum
Phase: Phase 2
Start: Oct 20, 2022
Completion: Nov 21, 2023
NCT06127212
Bioequivalence Study of Dapagliflozin 10 mg Film-coated Tablets
Start: Mar 8, 2023
Completion: May 6, 2023
NCT06127225
Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD)
Start: Apr 28, 2023
Completion: Aug 28, 2024
NCT06558058
Bioequivalence Study of Rivaroxaban 10 mg Film-coated Tablets
Start: Jun 8, 2023
Completion: Aug 29, 2023